To further investigate this, we analysed four paired cases with tissue from both primary and CNS metastasis and we sequenced TP53 to determine whether mutations associated with subsequent CNS metastasis were detectable in primary cancers (Figure 2). This evidence concerns the gene TP53 and cancer.